Q. Recently, the WHO granted approval for its first mpox vaccine for adults in which continent?
Answer:
Africa
Notes: The World Health Organization (WHO) recently approved its first Mpox vaccine for use in Africa. The vaccine, developed by Bavarian Nordic A/S, is a major step forward in tackling Mpox in the African region. With this approval, the vaccine can be pre-qualified for purchase by international donors like GAVI and UNICEF. Although there is limited supply due to having only one manufacturer, this vaccine is crucial for controlling outbreaks and enhancing public health in Africa.